| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis
|
Kirkham, Bruce W.
|
|
|
|
5 |
p. 1127-1146
|
artikel
|
| 2 |
Adverse Outcomes, Healthcare Resource Utilization, and Costs Associated with Systemic Corticosteroid use Among Adults with Systemic Lupus Erythematosus in the UK
|
Stirnadel-Farrant, Heide A.
|
|
|
|
5 |
p. 1167-1182
|
artikel
|
| 3 |
Artificial Intelligence in Rheumatoid Arthritis: Current Status and Future Perspectives: A State-of-the-Art Review
|
Momtazmanesh, Sara
|
|
|
|
5 |
p. 1249-1304
|
artikel
|
| 4 |
Characteristics of Patients with Primary Sjögren’s Syndrome and Non-specific Chronic Sialadenitis: A Subtype in Elderly Patients
|
Li, Hong-Xia
|
|
|
|
5 |
p. 1347-1359
|
artikel
|
| 5 |
Clinical and Economic Benefit of Advanced Therapies for the Treatment of Active Ankylosing Spondylitis
|
Walsh, Jessica A.
|
|
|
|
5 |
p. 1385-1398
|
artikel
|
| 6 |
Combination of Enzymes and Rutin to Manage Osteoarthritis Symptoms: Lessons from a Narrative Review of the Literature
|
Henrotin, Yves E.
|
|
|
|
5 |
p. 1305-1327
|
artikel
|
| 7 |
Comparison of the Effectiveness and Safety of Mycophenolate Mofetil and Cyclophosphamide in Lupus Nephritis: Evidence from a Real-World Study
|
Zhang, Xiaohui
|
|
|
|
5 |
p. 1199-1213
|
artikel
|
| 8 |
Correction: Experiences and Treatment Preferences in Patients With Psoriatic Arthritis: A Cross-Sectional Study in the ArthritisPower Registry
|
Ogdie, Alexis
|
|
|
|
5 |
p. 1477-1480
|
artikel
|
| 9 |
Correction to: Real-World Effectiveness and Treatment Retention of Secukinumab in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: A Descriptive Observational Analysis of the Spanish BIOBADASER Registry
|
Moreno-Ramos, Manuel José
|
|
|
|
5 |
p. 1475-1476
|
artikel
|
| 10 |
Development and Validation of a Machine Learning-Based Nomogram for Prediction of Ankylosing Spondylitis
|
Zhu, Jichong
|
|
|
|
5 |
p. 1377-1397
|
artikel
|
| 11 |
Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis
|
Lubrano, Ennio
|
|
|
|
5 |
p. 1119-1125
|
artikel
|
| 12 |
Febuxostat Therapy for Patients with Gout and Stage 2–4 CKD: a Retrospective Study
|
Zhang, Peiyu
|
|
|
|
5 |
p. 1421-1434
|
artikel
|
| 13 |
Filgotinib Modulates Inflammation-Associated Peripheral Blood Protein Biomarkers in Adults with Active Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate
|
Tanaka, Yoshiya
|
|
|
|
5 |
p. 1335-1348
|
artikel
|
| 14 |
Healthcare Resource Use and Costs Associated with Organ Damage in Newly Diagnosed Adults with Systemic Lupus Erythematosus in the UK
|
Stirnadel-Farrant, Heide A.
|
|
|
|
5 |
p. 1183-1197
|
artikel
|
| 15 |
Identifying and Quantifying the Role of Inflammation in Pain Reduction for Patients With Psoriatic Arthritis Treated With Tofacitinib: A Mediation Analysis
|
de Vlam, Kurt
|
|
|
|
5 |
p. 1451-1464
|
artikel
|
| 16 |
Infections in Biological and Targeted Synthetic Drug Use in Rheumatoid Arthritis: Where do We Stand? A Scoping Review and Meta-analysis
|
Bergmans, Barbara J. M.
|
|
|
|
5 |
p. 1147-1165
|
artikel
|
| 17 |
Is the Rate of Responders to Hyaluronic Acid Injection for Patients with Knee Osteoarthritis Stable Over Time? Post hoc Analyses of a 6-Month Follow-Up Study
|
Bruyere, Olivier
|
|
|
|
5 |
p. 1297-1303
|
artikel
|
| 18 |
Long-Term Efficacy and Safety of Risankizumab in Patients with Active Psoriatic Arthritis: Results from a 76-Week Phase 2 Randomized Trial
|
Mease, Philip J.
|
|
|
|
5 |
p. 1361-1375
|
artikel
|
| 19 |
Management of Specific Clinical Profiles in Axial Spondyloarthritis: An Expert’s Document Based on a Systematic Literature Review and Extended Delphi Process
|
García-Vicuña, Rosario
|
|
|
|
5 |
p. 1215-1240
|
artikel
|
| 20 |
Patients’ Needs Concerning Patient Education in Axial Spondyloarthritis: A Qualitative Study
|
van der Kraan, Yvonne M.
|
|
|
|
5 |
p. 1349-1368
|
artikel
|
| 21 |
PDCD5 as a Potential Biomarker for Improved Prediction of the Incidence and Remission for Patients with Rheumatoid Arthritis
|
Xiao, Juan
|
|
|
|
5 |
p. 1369-1383
|
artikel
|
| 22 |
Persistence and Use of Ixekizumab in Patients with Psoriatic Arthritis in Real-World Practice in Spain. The PRO-STIP Study
|
Joven, Beatriz
|
|
|
|
5 |
p. 1319-1333
|
artikel
|
| 23 |
Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis
|
Burmester, Gerd R.
|
|
|
|
5 |
p. 1255-1276
|
artikel
|
| 24 |
Racial and Ethnic Disparities in Treatment Initiation Among Patients with Newly Diagnosed Psoriatic Arthritis: A Retrospective Medicaid Claims Database Study
|
Patel, Aarti A.
|
|
|
|
5 |
p. 1241-1253
|
artikel
|
| 25 |
Real-World Immunosuppressant Treatment Patterns for Patients with Lupus Nephritis in the United States
|
Hunnicutt, Jacob N.
|
|
|
|
5 |
p. 1305-1318
|
artikel
|
| 26 |
Successful Chemical Synovectomy in a Patient with Acquired von Willebrand Syndrome with Chronic Synovitis Due to Recurrent Knee Hemarthrosis: A Case Report
|
Gualtierotti, Roberta
|
|
|
|
5 |
p. 1465-1474
|
artikel
|
| 27 |
The Economic Benefit of Remission for Patients with Rheumatoid Arthritis
|
Curtis, Jeffrey R.
|
|
|
|
5 |
p. 1329-1345
|
artikel
|
| 28 |
The Impact of Label Changes (Boxed Warning) on Real-World Febuxostat Utilization in Patients with Gout: A Cross-Sectional Drug Utilization Study
|
Sosinsky, Alexandra Z.
|
|
|
|
5 |
p. 1277-1295
|
artikel
|
| 29 |
Usage and Adherence of Seven Advanced Therapies with Differing Mechanisms of Action for Inflammatory Arthritis in Canada
|
Nantel, Francois
|
|
|
|
5 |
p. 1399-1420
|
artikel
|
| 30 |
Ustekinumab Is Rapid-Acting and Is an Effective Long-Term Treatment for Patients with Active Psoriatic Arthritis: Real-World Evidence from the Non-interventional SUSTAIN Study
|
Wendler, Jörg
|
|
|
|
5 |
p. 1435-1450
|
artikel
|
Tijdschrift beschrijving